Status:
UNKNOWN
Pharmacokinetics and Safety of DWJ1451 in Healthy Adults
Lead Sponsor:
Daewoong Pharmaceutical Co. LTD.
Conditions:
Healthy
Eligibility:
All Genders
19-55 years
Phase:
PHASE1
Brief Summary
Amlodipine, olmesartan, total ezetimibe, rosuvastatin AUCt, Cmax
Eligibility Criteria
Inclusion
- Age 19 to 55 years
- Healthy Adult
Exclusion
- Non-Healthy
Key Trial Info
Start Date :
March 13 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 2 2021
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04819932
Start Date
March 13 2021
End Date
April 2 2021
Last Update
March 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 54907